SIRT1 and nasopharyngeal carcinoma: EGCG promoted the growth inhibition and apoptosis of nasopharyngeal carcinoma (NPC) cell lines CNE-2 and 5-8F through inhibition of the SIRT1-p53 signaling pathway (69).